These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12197387)

  • 1. [Characterization of urokinase type plasminogen activator modified by phenylglyoxal].
    Mukhametova LI; Aĭsina RB; Lomakina GIu; Varfolomeev SD
    Bioorg Khim; 2002; 28(4):308-14. PubMed ID: 12197387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
    Gurewich V; Pannell R
    Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
    de Munk GA; Groeneveld E; Rijken DC
    Thromb Haemost; 1993 Sep; 70(3):481-5. PubMed ID: 8259553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN; Lee SC; Jackson KW; Tae WC; Schwartzott DG; McKee PA
    Thromb Haemost; 1998 Oct; 80(4):637-44. PubMed ID: 9798984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of single chain forms of urokinase-type plasminogen activator.
    Stump DC; Kieckens L; De Cock F; Collen D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):245-50. PubMed ID: 3612530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids.
    Braat EA; Nauland U; Dooijewaard G; Rijken DC
    Thromb Haemost; 1996 Jun; 75(6):908-14. PubMed ID: 8822585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of plasminogen activator inhibitor type 1 (PAI-1) for preventing single chain urokinase plasminogen activator (scu-PA) conversion into two chain urokinase plasminogen activator (tcu-PA) in plasma in vitro.
    Dosne AM; Dubor F; Samama M
    Thromb Res; 1991 Sep; 63(5):531-9. PubMed ID: 1755005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and characterization of clustered charge-to-alanine mutants of low M(r) single-chain urokinase-type plasminogen activator.
    Ueshima S; Holvoet P; Lijnen HR; Nelles L; Seghers V; Collen D
    Thromb Haemost; 1994 Jan; 71(1):134-40. PubMed ID: 8165632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the proteinase specificity in wild-type and stabilized plasminogen activator inhibitor-1: evidence for contribution of intramolecular flexibility.
    De Taeye B; Gils A; Vleugels N; Rabijns A; Declerck PJ
    Biochem Biophys Res Commun; 2004 Aug; 321(3):746-51. PubMed ID: 15358169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of single-chain urokinase and plasminogen activator inhibitor type 1.
    Manchanda N; Schwartz BS
    J Biol Chem; 1995 Aug; 270(34):20032-5. PubMed ID: 7544349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a recombinant chimeric plasminogen activator composed of Gly-Pro-Arg-Pro tetrapeptide and truncated urokinase-type plasminogen activator expressed in Escherichia coli.
    Hua ZC; Chen XC; Dong C; Zhu DX
    Biochem Biophys Res Commun; 1996 May; 222(2):576-83. PubMed ID: 8670247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by platelets.
    Baeten KM; Richard MC; Kanse SM; Mutch NJ; Degen JL; Booth NA
    J Thromb Haemost; 2010 Jun; 8(6):1313-22. PubMed ID: 20180903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential reactivity of Glu-Gly-Arg-CH2Cl, a synthetic urokinase inhibitor, with single-chain and two-chain forms of urokinase-type plasminogen activator.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1987 Jan; 162(2):351-6. PubMed ID: 3803392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and Characterization of a Mutant of Single-chain Urokinase-type Plasminogen Activator Ser(175)-His(187)-mscu-PA.
    Xue YM; Zhu H; Shi W; Liu W; Liu JN; Ma Z
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2000; 32(1):26-30. PubMed ID: 12110908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonradical oxidants of the phagocyte type induce the activation of plasmatic single chain- urokinase.
    Stief TW; Stief MH; Ehrenthal W; Darius H; Martin E
    Thromb Res; 1991 Dec; 64(5):597-610. PubMed ID: 1808764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-like plasminogen activator increased in plasma after alcohol drinking.
    Sumi H; Hamada H; Tsushima H; Mihara H
    Alcohol Alcohol; 1988; 23(1):33-43. PubMed ID: 3128990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood urokinase plasminogen activator system in chronic urticaria.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Arch Dermatol Res; 2007 Jan; 298(8):409-11. PubMed ID: 17102952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.